The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Rationale and Design of the IRON-CRT Trial: Effect of Intravenous Ferric Carboxymaltose on Reverse Remodelling Following Cardiac Resynchronization Therapy2019 · 17 citations
2. 2The effect of intravenous ferric carboxymaltose on right ventricular function – insights from the IRON‐CRT trial2022 · 19 citations
3. 3Iron Therapy and Severe Arrhythmias in HFrEF: Rationale, Study Design, and Baseline Results of the RESAFE-HF Trial2023 · 9 citations
4. 4Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency2025
5. 5Ferric Carboxymaltose for the Treatment of Iron-Deficient Heart Failure Patients: A Systematic Review and Meta-Analysis2020 · 30 citations